Physician profile
Mark C Durkin
NPI 1053320499
$5,891.28
in general payments reported to CMS, 2019-2025
18 companies · $192 in 2025
The $192 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,118 · 2020: $104 · 2021: $235 · 2022: $2,135 · 2023: $1,977 · 2024: $132 · 2025: $192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,232 · Food and Beverage: $1,068.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,232.48 |
| Food and Beverage | $1,067.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $2,674.39 | 2022-2025 | |
| Organogenesis INC. | $1,699.92 | 2019-2024 | Puraply, Apligraf |
| Smith+Nephew, INC. | $447.92 | 2019-2022 | |
| Paratek Pharmaceuticals, INC. | $203.86 | 2022-2023 | Nuzyra |
| Stryker Corporation | $147.76 | 2019 | |
| Medtronic, INC. | $131.23 | 2022-2024 | Intellis Adaptivestim |
| Bioventus LLC | $130.58 | 2019 | |
| Paragon 28, INC. | $125.83 | 2019-2025 | Portfolio |
| Grt US Holding, INC. | $102.53 | 2022 | |
| In2bones USA, LLC | $91.34 | 2020 | |
| Merck Sharp & Dohme LLC | $26.00 | 2019 | |
| Advanced Oxygen Therapy INC. | $22.17 | 2019-2022 | |
| Kerecis Limited | $18.44 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Vertex Pharmaceuticals Incorporated | $17.98 | 2025 | |
| Pfizer INC. | $14.20 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $12.45 | 2021 | |
| Integra Lifesciences Corporation | $12.40 | 2019 | |
| Amniox Medical, INC. | $12.28 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Durkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.